C12N 5/0647
Haematopoietic stem cells
Official title: {Haematopoietic stem cells; Uncommitted or multipotent progenitors}
C12N5/0647 (Haematopoietic stem cells) appears on 935 US grants and 1,821 published applications in this corpus.
Search patents in C12N- Granted patents
- 935
- Published applications
- 1,821
- Assignees
- 736
- Inventors
- 2,828
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 6 | 0 |
| 1994 | 3 | 0 |
| 1995 | 9 | 0 |
| 1996 | 8 | 0 |
| 1997 | 25 | 0 |
| 1998 | 21 | 0 |
| 1999 | 23 | 0 |
| 2000 | 13 | 0 |
| 2001 | 16 | 9 |
| 2002 | 20 | 41 |
| 2003 | 20 | 47 |
| 2004 | 9 | 50 |
| 2005 | 16 | 61 |
| 2006 | 16 | 44 |
| 2007 | 11 | 48 |
| 2008 | 17 | 44 |
| 2009 | 21 | 51 |
| 2010 | 21 | 67 |
| 2011 | 27 | 72 |
| 2012 | 22 | 45 |
| 2013 | 34 | 64 |
| 2014 | 37 | 63 |
| 2015 | 39 | 64 |
| 2016 | 50 | 69 |
| 2017 | 38 | 60 |
| 2018 | 49 | 99 |
| 2019 | 44 | 114 |
| 2020 | 52 | 117 |
| 2021 | 34 | 91 |
| 2022 | 49 | 116 |
| 2023 | 51 | 100 |
| 2024 | 52 | 117 |
| 2025 | 42 | 91 |
| 2026 | 33 | 77 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for promoting survival and proliferation of endothelial cells and stimulating angiogenesis6 Oct 2026US 12,753,384 B2Cornell Research Foundation, Inc.
- Methods of culturing quiescent hematopoietic stem cells and treatment methods6 Oct 2026US 12,753,389 B2Icahn School of Medicine at Mount Sinai
- Haematopoietic stem/progenitor cells29 Sep 2026US 12,747,424 B2Murdoch Childrens Research Institute
- Self-inactivating lentiviral vector comprising a FoxP3 expression cassette29 Sep 2026US 12,747,454 B2The Board of Trustees of the Leland Stanford Junior University
- Compositions and methods for providing hematopoietic function without HLA matching22 Sep 2026US 12,741,001 B2Fred Hutchinson Cancer Center
- Click chemistry assisted cell surface engineering for restoring lentivirus entry8 Oct 2026US 2026/0308632 A1The Children’s Hospital of Philadelphia
- Universal treatment of down syndrome1 Oct 2026US 2026/0294978 A1DEI Biopharma
- Genetically engineered human fetal liver niche as platform for biomanufacturing of hematopoietic stem cells1 Oct 2026US 2026/0297528 A1Arizona Board of Regents on behalf of Arizona State University
- Cell1 Oct 2026US 2026/0297622 A1Antion Biosciences SA
- Cells expressing parathyroid hormone 1 receptor and uses thereof24 Sep 2026US 2026/0286293 A1Tithon Biotech Inc.
Most cited
By later US patents
- Simultaneous stimulation and concentration of cells422US 6,797,514 B2XCYTE Therapies, Inc. · 2004
- Simultaneous stimulation and concentration of cells398US 6,867,041 B2XCYTE Therapies, Inc. · 2005
- Human hematopoietic stem cell388US 5,061,620 ASystemix, Inc. · 1991
- Simultaneous stimulation and concentration of cells383US 6,905,874 B2XCYTE Therapies, Inc. · 2005
- Adipose-derived stem cells and lattices313US 6,777,231 B1The Regents of the University of California · 2004